$DVAX

Dynavax Technologies Corp.

  • NASDAQ CAPITAL MARKET
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$8.95 ▼-3.348%

Last Close

VOLUME

2,295,847

DAY RANGE

8.8 - 9.29

52 WEEK

3.58 - 12.44

Join Discuss about DVAX with like-minded investors

AC
@achatzi #ivtrades
recently

$JMIA , $KND , $ZOM , $DVAX , $PLUG

122 Replies 13 👍 8 🔥

profile
@thegiz18 #ivtrades
recently

Lot of interesting earnings after close > @thegiz18 said: After close earnings today include $BYND, $ADSK, $BMRN, $CZR, $CVNA, $DELL, $DASH, $DVAX, $ETSY, $FTCH, $FSLR, $FSR, $GRPN, $HPQ, $NKLA, $QRTEA, $REGI, $RKT, $CRM, $SHAK, $STOR, $SFM, $RUN, $SPCE, $WDAY, $WW. $ZS that is a lot of stocks talked about on this group

136 Replies 14 👍 10 🔥

profile
@thegiz18 #ivtrades
recently

After close earnings today include $BYND, $ADSK, $BMRN, $CZR, $CVNA, $DELL, $DASH, $DVAX, $ETSY, $FTCH, $FSLR, $FSR, $GRPN, $HPQ, $NKLA, $QRTEA, $REGI, $RKT, $CRM, $SHAK, $STOR, $SFM, $RUN, $SPCE, $WDAY, $WW. $ZS that is a lot of stocks talked about on this group

40 Replies 10 👍 9 🔥

profile
@FUZZJP #ivtrades
recently

```Dynavax Technologies (NASDAQ: DVAX) and Valneva (OTCPK:INRLF) announce a commercial partnership for the supply of Dynavax's CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001.```

95 Replies 9 👍 14 🔥

profile
@Benlax #droscrew
recently

dvax is garbage

104 Replies 14 👍 9 🔥

TR
@TraderJack #ivtrades
recently

Yes, I had $NVAX since $13.5 and $DVAX since $6.00

148 Replies 12 👍 15 🔥

TR
@TraderJack #ivtrades
recently

Your guys can buy $AZN, $BMRN, $ALNY, $DVAX, $EBS, and $NBIX, these are the potential contractors for my vaccine. However, be careful that some of them will drop hard if they does not get my vaccine contracts...who will get the final deal is my insider information...secret..

78 Replies 12 👍 13 🔥

profile
@Benlax #droscrew
recently

fucking $DVAX

105 Replies 13 👍 12 🔥

TR
@TraderJack #ivtrades
recently

Everything related to vaccine go up a big....see my $NVAX and $DVAX. I need to speed up my own vaccine work...

53 Replies 13 👍 10 🔥

Key Metrics

Market Cap

1.03 B

Beta

1.83

Avg. Volume

2.03 M

Shares Outstanding

114.59 M

Yield

0%

Public Float

0

Next Earnings Date

2021-08-05

Next Dividend Date

Company Information

Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company's commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018 as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, pertussis and universal influenza.

CEO: Ryan Spencer

Website:

HQ: 2100 Powell Street Emeryville, 94608 California

Related News

  • Stock Equity

    Stocks Volume Buzz: Dynavax Technologies Corporation (NASDAQ:DVAX), Just Eat Takeaway.com N.V. American Depositary Shares (NYSE:GRUB)

    17 Jun 2021, 23:07
  • BioSpace

    Dynavax to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

    09 Jun 2021, 00:00
  • Jumbo News

    Emerging Trends in Cancer Vaccines Industry: Market Estimation 2021-2027 and Company Profiles: Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc (GSK), Immunocellular Therapeutics, and more

    07 Jun 2021, 21:42
  • Benzinga

    Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany

    27 May 2021, 12:47
  • FinanzNachrichten

    Bavarian Nordic A/S: Bavarian Nordic Announces Marketing and Distribution Agreement with Dynavax to Launch HEPLISAV B Hepatitis B Vaccine in Germany

    27 May 2021, 05:17